Why the study?
Mendelian randomization and therapeutic interventions raising HDL-C showed no CVD benefit, making the usefulness of HDL-C unclear, while the relevance of HDL particle characteristics, function, and subclasses to CVD remains controversial.
Key points are not available for this paper at this time.
Design
Review
Answers are grounded in this paper and cite their sources.
HDL-C levels alone are not a robust marker for cardiovascular protection, and future research should focus on HDL particle functionality and size rather than simply raising HDL-C.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Pappa et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: